SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001114220-17-000010
Filing Date
2017-05-04
Accepted
2017-05-04 16:36:34
Documents
54
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kerx-3312017x10q.htm 10-Q 493046
2 EXHIBIT 31.1 kerx-3312017x10qex311.htm EX-31.1 12901
3 EXHIBIT 31.2 kerx-3312017x10qex312.htm EX-31.2 12844
4 EXHIBIT 32.1 kerx-3312017x10qex321.htm EX-32.1 5924
5 EXHIBIT 32.2 kerx-3312017x10qex322.htm EX-32.2 5972
  Complete submission text file 0001114220-17-000010.txt   3299720

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kerx-20170331.xml EX-101.INS 531009
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kerx-20170331.xsd EX-101.SCH 31151
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kerx-20170331_cal.xml EX-101.CAL 52989
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kerx-20170331_def.xml EX-101.DEF 137614
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kerx-20170331_lab.xml EX-101.LAB 445283
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kerx-20170331_pre.xml EX-101.PRE 247539
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30929 | Film No.: 17814507
SIC: 2834 Pharmaceutical Preparations